Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul 25;283(30):21084-92.
doi: 10.1074/jbc.M710419200. Epub 2008 May 19.

G protein activation by the leukotriene B4 receptor dimer. Evidence for an absence of trans-activation

Marjorie Damian  1 , Sophie Mary, Aimée Martin, Jean-Philippe Pin, Jean-Louis Banères
Affiliations

G protein activation by the leukotriene B4 receptor dimer. Evidence for an absence of trans-activation

Marjorie Damian et al. J Biol Chem. .

Abstract

There is compelling evidence that G protein-coupled receptors exist as homo- and heterodimers, but the way these assemblies function at the molecular level remains unclear. We used here the purified leukotriene B(4) receptor BLT1 stabilized in its dimeric state to analyze how a receptor dimer activates G proteins. For this, we produced heterodimers between the wild-type BLT1 and a BLT1/ALXR chimera. The latter is no longer activated by leukotriene B(4) but is still activated by ALXR agonists. In this heterodimer, agonist binding to either one of the two protomers induced asymmetric conformational changes within the receptor dimer. Of importance, no G protein activation was observed when using a dimer where the ligand-loaded protomer was not able to trigger GDP/GTP exchange due to specific mutations in its third intracellular loop, establishing that the conformation of the agonist-free protomer is not competent for G protein activation. Taken together, these data indicate that although ligand binding to one protomer in the heterodimer is associated with cross-conformational changes, a trans-activation mechanism where the ligand-free subunit would trigger GDP/GTP exchange cannot be considered in this case for G protein activation. This observation sheds light into the way GPCR dimers, in particular heterodimers, could activate their cognate G proteins.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Ligand binding to BLT1chim. Shown are direct binding of the ALXR 125I-labeled WKYMVm agonist (A) and 125I-labeled WKYMVm displacement by LXA4 (closed circles) or LTB4 (open circles) (B). Ligand-binding experiments were carried out by equilibrium dialysis as described under “Experimental Procedures.” The direct binding data are presented as a plot of the binding degree X as a function of the ligand concentration. The binding degree is defined by bound mol of ligand/mol of receptor. The experiments illustrated here are representative of three independent trials, each performed in duplicate.
FIGURE 2.
FIGURE 2.
Agonist-induced receptor activation. Shown are fluorescence emission spectra of 5HW-labeled wild-type (A) or chimeric (B) receptors in the absence of ligand (free) or in the presence of LTB4 or LXA4. Fluorescence emission spectra were recorded as described under “Experimental Procedures.”
FIGURE 3.
FIGURE 3.
Receptor-catalyzed [35S]GTPγS binding to the G protein. GDP/GTP exchange on Gαi catalyzed by BLT1 or BLT1chim in the presence of saturating concentrations in LTB4 or LXA4, respectively. Data are expressed as the percentage of maximal binding. In all cases, data represent the mean ± S.E. from three independent experiments.
FIGURE 4.
FIGURE 4.
Ligand binding to the BLT1-BLT1chim heterodimer. Ligand-binding experiments were carried out by equilibrium dialysis as described under “Experimental Procedures” using 3H-labeled LTB (A) or 125I-labeled WKYMVm (B). The binding experiments were carried out in the presence (open symbols) or absence (closed symbols) of 500 μm WKYMVm (A) or LTB4 (B). The binding data are presented as a plot of the binding degree X as a function of the ligand concentration. The binding degree is defined by bound mol of ligand/mol of receptor. The experiments illustrated here are representative of three independent trials, each performed in duplicate.
FIGURE 5.
FIGURE 5.
BLT1-BLT1chim-catalyzed [35S]GTPγS binding to the G protein. GDP/GTP exchange on Gαi catalyzed by the BLT1-BLT1chim heterodimer in the absence of agonist, in the presence of saturating concentrations in LTB4 or in the presence of saturating concentrations in LXA4. Data are expressed as the percentage of maximal binding. In all cases, data represent the mean S.E. from three independent experiments.
FIGURE 6.
FIGURE 6.
Receptor activation in the BLT1-BLT1chim heterodimer. A, relative change in 5HW fluorescence in the BLT1-BLT1chim dimer where either of the protomers is labeled with 5HW in the absence of agonist or in the presence of either LTB4 or LXA4. The species analyzed are schematically depicted in each case, where the open box represents the wild-type protomer, the gray box represents the BLT1chim protomer, and the star represents 5HW labeling. B, relative change in 5HW fluorescence in the BLT1-BLT1chim dimer, where the labeled protomer is the chimeric one in the absence of ligand, after the addition of LTB4, or after the addition of LTB4 and then LXA4. In all of the cases, the error bar corresponds to the S.D. value calculated from three independent experiments.
FIGURE 7.
FIGURE 7.
Cross-conformational changes in the R-Rchim heterodimer. Fluorescence emission changes of 5HW-labeled R (profiles 1 and 3) or Rchim (profiles 2 and 4) as a function of time. LTB4 was first bound to the R protomer in the R-Rchim dimer, a large excess in LXA4 was added (LXA4/LTB4 ratio 1000:1), and the changes in the emission properties were recorded as a function of time. Measurements were carried out in the absence (profiles 1 and 2) or the presence (profiles 3 and 4) of 0.1 mm GTP.
FIGURE 8.
FIGURE 8.
BLT1i3-1-BLT1chim-catalyzed [35S]GTPγS binding to the G protein. A, GDP/GTP exchange on Gαi catalyzed by BLT1 or BLT1i3-1 in the presence of saturating concentrations in LTB4. Data are expressed as the percentage of maximal binding. The species analyzed are schematically depicted in each case, where the open box represents the wild-type protomer and the cross represents the i3-1 mutation. In all cases, data represent the mean S.E. from three independent experiments. B, GDP/GTP exchange on Gαi (open boxes) or Gαo (closed boxes) catalyzed by the BLT1i3-1-BLT1chim heterodimer in the absence of agonist, in the presence of saturating concentrations in LTB4 or in the presence of saturating concentrations in LXA4. Data are expressed as the percentage of maximal binding. The species analyzed are schematically depicted in each case where the open box represents the wild-type protomer, the gray box represents the BLT1chim protomer, the cross represents the i3-1 mutation, and the black box represents the ligand. In all cases, data represent the mean S.E. from three independent experiments.
FIGURE 9.
FIGURE 9.
A model for BLT1-BLT1chim-induced G protein activation. The white box corresponds to BLT1, and the gray box corresponds to BLT1chim. The G protein is represented by the box marked G. The different shapes correspond to the different conformations adopted by the receptor. Binding of the agonist to one of the protomers (e.g. BLT1) induces a conformational change of the ligand-loaded subunit and a cross-conformational change of the ligand-free protomer. However, only the agonist-loaded protomer can trigger G protein activation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bockaert, J., and Pin, J. P. (1999) EMBO J. 18 1723-1729 - PMC - PubMed
    1. Bockaert, J., Claeysen, S., Becamel, C., Pinloche, S., and Dumuis, A. (2002) Int. Rev. Cytol. 212 63-132 - PubMed
    1. Kobilka, B. K. (2007) Biochim. Biophys. Acta 1768 794-807 - PMC - PubMed
    1. Whorton, M. R., Bokoch, M. P., Rasmussen, S. G., Huang, B., Zare, R. N., Kobilka, B., and Sunahara, R. K. (2007) Proc. Natl. Acad. Sci. U. S. A. 104 7682-7687 - PMC - PubMed
    1. Whorton, M. R., Jastrzebska, B., Park, P. S., Fotiadis, D., Engel, A., Palczewski, K., and Sunahara, R. K. (2007) J. Biol. Chem. 283 4387-4394 - PMC - PubMed

Publication types

LinkOut - more resources